15th edition of CMS European M&A Study is available now

16th Edi­tion

Press re­lease - 22.03.2023An in­ter­na­tion­al team of ex­perts from CMS ad­vised the AL­PLA Group on es­tab­lish­ing a joint ven­ture with the Span­ish pack­aging com­pany In­den Pharma. The core CMS Vi­enna team, led by Al­ex­an­der Rakosi, in­cluded Flori­an May­er and Anna Hiegel­sper­ger.   The AL­PLA Group and In­den Pharma have strengthened their pres­ence in the phar­ma­ceut­ic­al mar­ket by found­ing a joint ven­ture. AL­PLA Pharma is con­trib­ut­ing pro­duc­tion sites in Greece and Po­land to the co­oper­a­tion and In­den Pharma two plants in Spain. To­geth­er they plan to set up a site in Ger­many and triple their pro­duc­tion over the next five years. Such cross-bor­der joint ven­ture pro­jects present nu­mer­ous leg­al chal­lenges, whose suc­cess­ful im­ple­ment­a­tion re­quires seam­less co­oper­a­tion between in­ter­na­tion­ally ex­per­i­enced teams from vari­ous prac­tice groups and jur­is­dic­tions. The ex­pert team for the cur­rent AL­PLA deal in­cluded law­yers from CMS of­fices in Aus­tria, Spain, Ger­many and Po­land.Al­ex­an­der Rakosi, Part­ner at CMS Vi­enna and re­spons­ible for the suc­cess­ful con­clu­sion of the joint ven­ture says: "Cross-bor­der tech­no­logy and know-how trans­fer are be­com­ing in­creas­ingly im­port­ant for our cli­ents’ sus­tain­able eco­nom­ic suc­cess. We are there­fore de­lighted to have made a valu­able con­tri­bu­tion to this deal with our glob­al CMS net­work, our in­ter­na­tion­al ex­per­i­ence and our in-depth ex­pert­ise on cross-bor­der deals."The CMS Aus­tria team con­sisted of cor­por­ate/M&A ex­perts Al­ex­an­der Rakosi, Flori­an May­er, Anna Hiegel­sper­ger, Livia Land­sk­ron, Ra­mona Mu­jan­ovic, Re­becca Herl­itz, Rupert Riedl and Han­nah Gi­er­linger. The In­tel­lec­tu­al Prop­erty de­part­ment was rep­res­en­ted by Hans Le­der­er. Di­eter Zand­ler, Vanessa Hor­aceck and Stefan Sottner were deal­ing with an­ti­trust and com­pet­i­tion law is­sues.The CMS Spain team, led by Lu­is Miguel De Di­os and Jorge Per­is Hev­ia, also in­cluded cor­por­ate/M&A ex­perts Ana Vázquez Re­cio, Lucía Signes de Mesa and Saphira Mouza­yek. Víct­or San­juán Mira, María José Ramos Aguilar, Guillermo Gar­cía Diéguez, Irene San Martín Gar­cía and Ri­cardo Gómez-Barreda de la Gándara were also in­volved in the due di­li­gence pro­cess. Tax law ex­pert­ise was provided by Ri­cardo Héct­or and Marta Bur­gos Mur­illo.The CMS Ger­many team in­cluded Malte Bruhns, Laura Christin Stein, Christin Fisc­her and Mor­itz Zie­g­ler.The CMS Po­land team con­sisted of Blazej Zagor­ski, Joanna Bia­loskor­ska and Aleksandra Da­lecka.

The CMS Cor­por­ate/M&A Group is pleased to launch the 15th edi­tion of the European M&A Study

Di­git­al Health Apps/Soft­ware 1. How is the soft­ware with­in di­git­al health apps clas­si­fied in your jur­is­dic­tion, and what reg­u­la­tion(s) ap­ply? 1.1 Is it con­sidered a “med­ic­al device” or a “product”...